Research Studies Enrolling New Participants

We provide access to national and local clinical research trials and studies for persons with HIV and other infectious diseases in Hawaii, funded by the National Institutes of Health and other agencies. Trial enrollment is open to the general public.

Open Enrollment

(Last updated March 17, 2025)

Local studies

• Title: H058: Factors Responsible for the Development of Pulmonary Post-Acute Sequelae of SARS-CoV-2 Infection (PPASC) in Hawaii (V.2.3; 2/22/24)
  • Project Summary: This study will be to elucidate pathophysiologic role of monocytes in the development and persistence of pulmonary Post-Acute Sequelae of SARS-CoV-2 infection and how macro-social and psychological determinants may influence these biological mechanisms.
  • Do you meet any of the following criteria:
    • Breathing Problems after having COVID-19
    • Fully Recovered from COVID-19
    • Never had COVID-19
    • 18 years old and up
  • Contact:
    • Telephone: 808-978-0751
    • Email: PPCOVID@hawaii.edu
  • Links:
    • NIH: https://reporter.nih.gov/search/lqNj8-c7c0qS41rFZvHzHw/project-details/10894228
    • Ola Hawaii: https://ola.jabsom.hawaii.edu/research-projects/devendra-park-research-project/

National studies

• Title: RECOVER-AUTONOMIC: A Platform Protocol for Evaluation of Interventions for Autonomic Dysfunction in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
  • Study description: This protocol is a prospective, multi-center, multi-arm, randomized, controlled platform trial evaluating various interventions for use in the treatment of autonomic dysfunction symptoms, including cardiovascular complications and postural orthostatic tachycardia syndrome (POTS), in PASC participants.
  • Who: We are investigating potential treatments for adults experiencing symptoms related to Long COVID, particularly those related to autonomic dysfunction, such as rapid heart rate, dizziness, and fatigue upon standing up from a sitting or lying position.  
  • Contact:
    • Telephone: 808-766-1216
    • Email: recauto@hawaii.edu
  • Links:
    • Clinical Trials: https://clinicaltrials.gov/study/NCT06305780?term=NCT06305780&rank=1
    • RECOVER: https://trials.recovercovid.org/autonomic
• Title: Effect of Immulina™ Supplements on Inflammatory Biomarkers Correlated with Clinical Symptoms in Patients with Long COVID (PASC)
  • Study description: The purpose of this study is to learn the effects of Immulina™, a natural dietary supplement derived from a microbe called Spirulina, on specific immune substances (called biomarkers) in the blood that are associated with improving the ability to “bounce back” against long-term symptoms caused by a COVID-19 infection.
  • Inclusion criteria:
    • Current Symptom(s)
      • Brain Fog
      • Persistent fatigue
      • Persistent shortness of breath
    • 18 years old and up
  • Contact:
    • Telephone: 808-723-0040
    • Email: covid@hawaii.edu
  • Links:
    • Clinical trials: https://clinicaltrials.gov/study/NCT05524532